XML 49 R20.htm IDEA: XBRL DOCUMENT

Segment Information

12 Months Ended

Jun. 30, 2025

14.

SEGMENT INFORMATION

After the BIOX deconsolidation, that took place in June 24, 2025 the Group is organized under a single operating segment, which is “science-based food ingredients”. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the chief operating decision maker, who in the Group’s case is the Executive Team, in deciding how to allocate resources and assess performance. The Executive Team is composed of the Chief Executive Officer (“CEO”), the Chief Financial Officer (“CFO”) and the Chief Technology Officer (“CTO”).

Prior to the BIOX deconsolidation, the Executive Team evaluates the Group’s financial information and resources and assess the financial performance of these resources as follows:

Seed and integrated products

The seed and integrated products segment focuses mainly on the development and commercialization of seed technologies and products that increase yield per hectare, with a focus on the provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics, to improve nutritional value and other benefits. The segment focuses on the commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments—in order to increase crop productivity and create value for customers. While each component can increase yield independently, through an integrated technology strategy the segment offers products that complement and integrate with each other to generate higher yields in crops.

Currently the segment generates revenue from ordinary activities through the sale of seeds, integrated product packs, royalties and licenses charged to third parties, among others.

Crop protection

The crop protection segment mainly includes the development, production and marketing of high-tech adjuvants and a full range of pest control molecules and biocontrol products. Adjuvants are used in mixtures to facilitate the application and effectiveness of active ingredients, such as insecticides, leading to better performance, reduced usage rates and lower residue levels Insecticides and fungicides are applied to control pests and significantly reduce disease during the germination period.

The segment currently generates revenue from ordinary activities through the sale of adjuvants, insecticides, fungicides, and baits, among others.

Crop nutrition

The crop nutrition segment focuses mainly on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers including biofertilizers and microgranulated fertilizers that optimize the productivity and yield of the crops.

Currently the segment generates income from ordinary activities through the sale of inoculants, bio-inductors, biological fertilizers and microgranulated fertilizers, among others.

The measurement principles for the Group’s segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products and services exchanged between segments and entities within the Group are calculated based on market prices.

Emerging solutions

The emerging solution segment is based on providing R&D services, biotechnology capabilities and specialised expertise to facilitate the integration of technologies and product development efforts within the Group, as well as R&D services to third parties.

This segment includes revenue sources primarily related to agro-industrial biotechnology businesses, such as those generated by the production and commercialization of industrial enzymes and fermentation technology to convert sugars and oils into high-value molecules or compounds.

The following tables present information with respect to the Group’s reporting segments:

Year ended June 30, 2025	Seed and integrated products			Crop protection			Crop nutrition			Emerging solutions			Consolidated
Revenues from contracts with customers
Sale of goods and services		60,535,026			181,908,584			76,054,689			267,261			318,765,560
Royalties		1,414,864			-			-			-			1,414,864
Right of use licenses		-			-			13,430,824			-			13,430,824
Others
Initial recognition and changes in the fair value of biological assets at the point of harvest		1,764,863			-			-			-			1,764,863
Government grants		-			-			-			3,412			3,412
Total revenues		63,714,753			181,908,584			89,485,513			270,673			335,379,523

Cost of sales		(44,727,989	)		(111,888,640	)		(46,808,243	)		-			(203,424,872	)
Gross profit per segment		18,986,764			70,019,944			42,677,270			270,673			131,954,651
% Gross margin		30	%		38	%		48	%		100	%		39	%

Year ended June 30, 2024	Seed and integrated products			Crop protection			Crop nutrition			Emerging solutions			Consolidated
Revenues from contracts with customers
Sale of goods and services		94,457,404			223,538,317			125,558,380			1,547,782			445,101,883
Royalties		986,602			-			-			-			986,602
Right of use licenses		1,000,000			-			19,287,845			-			20,287,845
Others
Initial recognition and changes in the fair value of biological assets at the point of harvest		(45,746	)		-			-			-			(45,746	)
Government grants		-			-			-			197,519			197,519
Total revenues		96,398,260			223,538,317			144,846,225			1,745,301			466,528,103

Cost of sales		(66,306,974	)		(143,807,301	)		(68,107,537	)		(1,146,516	)		(279,368,328	)
Gross profit per segment		30,091,286			79,731,016			76,738,688			598,785			187,159,775
% Gross margin		31	%		36	%		53	%		34	%		40	%

Year ended June 30, 2023	Seed and integrated products			Crop protection			Crop nutrition			Emerging solutions			Consolidated
Revenues from contracts with customers
Sale of goods and services		55,360,397			205,685,451			157,153,024			1,420,990			419,619,862
Royalties		1,247,567			-			-			-			1,247,567
Others
Initial recognition and changes in the fair value of biological assets at the point of harvest		319,428			153,460			137,666			-			610,554
Government grants		-			-			-			93,509			93,509
Total revenues		56,927,392			205,838,911			157,290,690			1,514,499			421,571,492

Cost of sales		(31,012,687	)		(137,529,299	)		(66,915,067	)		(7,019	)		(235,464,072	)
Gross profit per segment		25,914,705			68,309,612			90,375,623			1,507,480			186,107,420
% Gross margin		46	%		33	%		57	%		100	%		44	%

	06/30/2025		06/30/2024		06/30/2023
Revenue by similar group of products or services
Seed and integrated products		61,949,890		96,444,006		56,607,954
Seed Treatments Packs		28,476,396		29,992,052		32,563,161
Seed & Royalties Payments & HB4 Program		33,473,494		66,451,954		24,044,803

Crop protection		181,908,584		223,538,317		205,685,451
Adjuvants		56,028,937		56,634,128		52,825,245
Seed CP Products and Services		28,890,840		34,877,911		26,080,587
Other CP Products and Services		62,983,430		103,092,454		94,277,444
Bioprotection		34,005,377		28,933,824		32,502,175

Crop nutrition		89,485,513		144,846,225		157,153,024
Inoculants & Biofertilizers		22,445,093		18,315,253		23,621,534
Micro-beaded Fertilizers		56,461,771		91,786,942		90,827,714
Biostimulants		10,578,649		15,456,185		9,800,318
Syngenta up-front fee		-		19,287,845		32,903,458

Emerging solutions		270,673		1,745,301		1,514,499
Management expenses		267,261		1,547,782		1,420,990
Government grants		3,412		197,519		93,509

Total revenues		333,614,660		466,573,849		420,960,938

As of the current period, geographical information is reported by main countries and regions. LATAM refers to Latin America countries, excluding Argentina and Brazil which are reported separately. North America includes United States of America and Canada. The EMEA region covers Europe, the Middle East and Africa. The Group has recast the comparative figures accordingly.

Geographical information

	06/30/2025		06/30/2024		06/30/2023

Argentina		231,823,079		348,366,339		289,346,766
Brazil		17,673,809		24,175,116		23,690,028
LATAM		23,900,621		21,952,339		21,044,547
North America		30,107,865		27,543,558		30,768,912
EMEA		7,920,550		21,320,535		22,014,855
Rest of the world		22,188,736		23,215,962		34,095,830
Total revenues		333,614,660		466,573,849		420,960,938

	06/30/2025		06/30/2024
Non-current assets
Argentina		12,493,920		139,722,896
Brazil		-		7,698,175
LATAM		-		1,162,654
North America		53,447,180		189,199,549
EMEA		12,662,860		44,141
Rest of the world		-		26,279,731
Total		78,603,960		364,107,146

Property, plant and equipment		3,345,170		74,612,434
Intangible assets		75,258,790		177,331,280
Goodwill		-		112,163,432
Total reportable assets		78,603,960		364,107,146
Total non-reportable assets		126,105,586		585,729,699
Total assets		204,709,546		949,836,845

Following the Business Combination and the BIOX deconsolidation, the Executive team will evaluate the Group’s financial information and resources and assess the financial performance of these resources on a consolidated basis on the basis of Net revenue/loss for the period.